Subarachnoid hemorrhage and intracerebral hemorrhage are important causes of stroke. In spite of the common occurrence of hemorrhage, little is known about how blood and the hemoglobin in blood are metabolized in the CNS, what role hemoglobin might play in mediating injury, and whether there are specific therapeutic approaches that improve outcome from hemorrhage. Hemoglobin contributes to oxidative stress and produces vasospasm when placed around cerebral blood vessels. This proposal will examine the role of the HO-1 and HO-2 hemeoxygenase enzymes in the brain since they are two of the enzymes that metabolize heme in hemoglobin. Subarachnoid injections of whole blood, lysed blood or hemoglobin induce hemeoxygenase-1 (HO-1) in microglia throughout the entire brain. Subarachnoid injections of lysed blood induced the HSP70, HO-1 and HSP47 stress genes in focal regions of rodent brain. The focal regions of heat shock gene injection can be blocked by pre-treatment with anti-oxidant drugs. This proposal will continue to examine experimental subarachnoid hemorrhages produced by injections of lysed blood into the cisterna magna of adult rats or mice. The following series of experiments will test three major hypotheses. (1) Hypothesis: The focal regions of stress gene induction following experimental subarachnoid hemorrhage are ischemic. Experiments: (1) Blood flow, glucose metabolism and the blood brain barrier will be examined in focal regions of stress gene expression following experimental subarachnoid hemorrhage. (2) Hypothesis: HO-1 and HO-2 protect against experimental subarachnoid hemorrhage. Experiments: (2) Focal stress gene expression will be assessed following experimental subarachnoid hemorrhage in HO-1 and HO-2 knockout mice, and following induction of HO-1 with either systemic or subarachnoid injections of pure hemoglobin or stabilized hemin. (3) Hypothesis: Drugs that protect against oxidative stress and ischemic injury block focal regions of stress gene expression following experimental subarachnoid hemorrhage. Experiments: (3) Focal stress gene expression due to subarachnoid hemorrhage will be assessed following treatment with nimodipine, potent anti-oxidants like spin-trap compounds, and following treatment with glutamate receptor antagonists. These studies will help delineate mechanisms of injury following subarachnoid hemorrhage, and will develop a new approach for assessing whether drugs decrease or block injury due to subarachnoid hemorrhage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS038084-01
Application #
2737821
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Jacobs, Tom P
Project Start
1999-05-01
Project End
2000-02-29
Budget Start
1999-05-01
Budget End
2000-02-29
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northern California Institute Research & Education
Department
Type
DUNS #
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Lit, Lisa; Gilbert, Donald L; Walker, Wynn et al. (2007) A subgroup of Tourette's patients overexpress specific natural killer cell genes in blood: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 144B:958-63
Clark, Joseph F; Sharp, Frank R (2006) Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:1223-33
Tang, Yang; Gilbert, Donald L; Glauser, Tracy A et al. (2005) Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 62:210-5
Tang, Yang; Lu, Aigang; Ran, Ruiqiong et al. (2004) Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Brain Res Mol Brain Res 132:155-67
Hershey, Andrew D; Tang, Yang; Powers, Scott W et al. (2004) Genomic abnormalities in patients with migraine and chronic migraine: preliminary blood gene expression suggests platelet abnormalities. Headache 44:994-1004
Tang, Yang; Schapiro, Mark B; Franz, David N et al. (2004) Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Ann Neurol 56:808-14
Tang, Yang; Nee, Alex C; Lu, Aigang et al. (2003) Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab 23:310-9
Mancuso, Anthony; Derugin, Nikita; Hara, Kazushi et al. (2003) Cyclooxygenase-2 mRNA expression is associated with c-fos mRNA expression and transient water ADC reduction detected with diffusion MRI during acute focal ischemia in rats. Brain Res 961:121-30
Clark, Joseph F; Reilly, Melinda; Sharp, Frank R (2002) Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm. J Cereb Blood Flow Metab 22:472-8
Lu, Aigang; Ran, Ruiqiong; Parmentier-Batteur, Sophie et al. (2002) Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem 81:355-64

Showing the most recent 10 out of 12 publications